Q1 2 May with ABG +8% vs. cons. on low-visibility quarter. All days at potential new targets at CMD 7 May, little news on Q1. We stay BUYers on cheap turnaround potential.

24 Apr 2024
A decent Q1 while we await the CMD

Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
A decent Q1 while we await the CMD
- Published:
24 Apr 2024 -
Author:
ABGSC Healthcare Research | Morten Larsen -
Pages:
11 -
Q1 2 May with ABG +8% vs. cons. on low-visibility quarter. All days at potential new targets at CMD 7 May, little news on Q1. We stay BUYers on cheap turnaround potential.